Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-κB activation?

Antioxidants and Redox Signaling

Volumn 3, Issue 2, 2001, Pages 329-340

  Renard, Patricia ^a   Delaive, Edouard ^a   Van Steenbrugge, Martine ^a   Remacle, José ^a   Raes, Martine ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMIN; GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; PYRROLIDINE DITHIOCARBAMATE;

ANTIOXIDANT ACTIVITY; ARTICLE; CAPILLARY ELECTROPHORESIS; CELL ADHESION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

EID: 0035000953     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308601300185269     Document Type: Article

References (49)

1. Anderson MT, Staal FJ, Gitler C, Herzenberg LA, and Herzenberg LA. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci U S A 91: 11527-11531, 1994.
2. Baeuerle PA, and Baichwal VR. NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65: 111-137, 1997.
3. Baeuerle PA, and Baltimore D. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor. Cell 53: 211-217, 1988.
4. Bauskin AR, Alkalay I, and Ben-Neriah Y. Redox regulation of protein tyrosine kinase in the endoplasmic reticulum. Cell 66: 685-696, 1991.
5. Bessho R, Matsubara K, Kubota M, Kuwakado K, Hirota H, Wakazano Y, Wei Lin Y, Okuda A, Kawai M, Nishikimori R, and Heike T. Pyrrolidine dithiocarbamate, a potent inhibitor of nuclear factor κB (NF-κB) activation, prevents apoptosis in human promyelocytic leukemia HL-60 cells and thymocytes. Biochem Pharmacol 48: 1883-1889, 1994.
6. Bonizzi G, Dejardin E, Piret B, Piette J, Merville MP, and Bours V. Interleukin-1 beta induces nuclear factor kappa B in epithelial cells independently of the production of reactive oxygen intermediates. Eur J Biochem 242: 544-549, 1996.
7. 2 in NF-kappaB activation by either cytokine in both primary and transformed endothelial cells. J Biol Chem 272: 25941-25950, 1997.
8. Brennan P, and O'Neill LA. 2-Mercaptoethanol restores the ability of nuclear factor kappa B (NF kappa B) to bind DNA in nuclear extracts from interleukin 1-treated cells incubated with pyrrolidine dithiocarbamate (PDTC). Evidence for oxidation of glutathione in the mechanism of inhibition of NF kappa B by PDTC. Biochem J 320: 975-981, 1996.
9. Brennan P, and O'Neill LA. Inhibition of NF kappa B activity by oxidative processes in intact cells. Mechanism of action of pyrrolidine dithiocarbamate and diamide. Biochem Soc Trans 24: 3S, 1996.
10. Cao Z, Henzel W, and Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science 271: 1128-1131, 1996.
11. Davies MJ, Forni LG, and Willson RL. Vitamin E analogue Trolox C. E.S.R. and pulse-radiolysis studies of free-radical reactions. Biochem J 255: 513-522, 1988.
12. Dröge W, Schulze-Osthoff K, Mihm S, Galter D, Schenk H, Eck HP, Roth S, and Gmunder H. Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 8: 1131-1138, 1994.
13. Eugui EM, DeLustro B, Rouhafza S, Ilnicka M, Lee SW, Wilhelm R, and Allison AC. Some antioxidants inhibit, in a co-ordinate fashion, the production of tumor necrosis factor-alpha, IL-beta, and IL-6 by human peripheral blood mononuclear cells. Int Immunol 6: 409-122, 1994.
14. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol 10: 248-253, 1998.
15. Flohe L, Brigelius-Flohe R, Saliou C, Traber MG, and Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med 22: 1115-1126, 1997.
16. Galter D, Mihm S, and Droge W. Distinct effects of glutathione disulfide on the nuclear transcription factor κB and the activator protein-1. Eur J Biochem 221: 639-648, 1994.
17. Guan K, and Dixon JE. Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J Biol Chem 266: 17026-17030, 1991.
18. Guy GR, Cairns J, Ng SB, and Tan YH. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J Biol Chem 268: 2141-2148, 1993.
19. Halliwell B, and Gutteridge JM. Free Radicals in Biology and Medicine. Oxford, U.K.: Clarendon Press, 1989, p. 543.
20. Hartman PE. Ergothioneine as antioxidant. Methods Enzymol 186: 310-318, 1990.
21. Jakob U, Muse W, Eser M, and Bardwell JC. Chaperone activity with a redox switch. Cell 96: 341-352, 1999.
22. Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, and Sartor RB. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163: 3474-3483, 1999.
23. Kretz-Remy C, Mehlen P, Mirault ME, and Arrigo AP. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J Cell Biol 133: 1083-1093, 1996.
24. Kumar A, Dhawan S, Hardegen NJ, and Aggarwal BB. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-kappaB activation. Biochem Pharmacol 55: 775-783, 1998.
25. Kunchandy E, and Rao MN. Oxygen radical scavenging activity of curcumin. Int J Pharmaceut 58: 237-240, 1990.
26. Kuo M-L, Hunag T-S, and Lin JK. Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317: 95-100, 1996.
27. Matthews JR, Kaszubska W, Turcatti G, Wells TN, and Hay RT. Role of cysteine 62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res 21: 1727-1734, 1993.
28. Meier B, Radeke HH, Selle S, Habermehl GG, Resch K, and Sies H. Human fibroblasts release low amounts of reactive oxygen species in response to the potent phagocyte stimulants, serum-treated zymosan, N-formyl-methionyl-leucyl-phenylalanine, leukotriene B4 or 12-O-tetradecanoylphorbol 13-acetate. Biol Chem Hoppe Seyler 371: 1021-1025, 1990.
29. Mercurio F, and Manning AM. Multiple signals converging on NF-kappaB. Curr Opin Cell Biol 11: 226-232, 1999.
30. Nakayama T, Yamada M, Osawa T, and Kawakishi S. Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem Pharmacol 45: 265-267, 1993.
31. Orrenius S, Nobel CS, van den Dobbelsteen DJ, Burkitt MJ, and Slater AF. Dithiocarbamates and the redox regulation of cell death. Biochem Soc Trans 24: 1032-1038, 1996.
32. Piccoli G, Fiorani M, Biagiarelli B, Palma F, Potenza L, Amiucci A, and Stocchi V. Simultaneous high-performance capillary electrophoretic determination of reduced and oxidized glutathione in red blood cells in the femtomole range. J Chromatogr A 676: 239-246, 1994.
33. Radeke HH, Meier B, Topley N, Flöge J, Habermehl GG, and Resch K. Interleukin 1-α and tumour necrosis factor-α induce oxygen radical production in mesangial cells. Kidney Int 37: 767-775, 1990.
34. Reed DJ. Review on the current status of calcium and thiols in cellular injury. Chem Res Toxicol 3: 495-502, 1990.
35. Renard P, Zachary M-D, Bougelet C, Mirault M-E, Haegeman G, Remade J, and Raes M. Effects of antioxidant enzyme modulations on interleukin-1-induced nuclear factor kappa B activation. Biochem Pharmacol 53: 149-160, 1997.
36. Rodriguez M, Wright J, Thompson J, Thomas D, Baleux F, Virelizier J, Hay R, and Arenzana-Seisdedos F. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 12: 2425-2435, 1996.
37. Rupec RA, and Baeuerle PA. The genomic response of tumor cells to hypoxia and reoxygenation - Differential activation of transcription factors AP-1 and NF-kappa B. Eur J Biochem 234: 632-640, 1995.
38. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
39. Schreck R, Albermann K, and Baeuerle PA. Nuclear factor KB: an oxidative stress responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17: 221-237, 1992.
40. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, and Fiers W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12: 3095-3104, 1993.
41. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55: 1747-1758, 1998.
42. Sen CK, Khanna S, Reznick AZ, Roy S, and Packer L. Glutathione regulation of tumor necrosis factor-alpha-induced NF-kappa B activation in skeletal muscle-derived L6 cells. Biochem Biophys Res Commun 237: 645-649, 1997.
43. Shea LM, Beehler C, Schwartz M, Shenkar R, Tuder R, and Abraham E. Hyperoxia activates NF-kappa B and increases TNF-alpha and IFN-gamma gene expression in mouse pulmonary lymphocytes. J Immunol 157: 3902-3908, 1996.
44. Staal FJ, Roederer M, Herzenberg LA, and Herzenberg LA. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A 87: 9943-9947, 1990.
45. Suzuki YJ, and Packer L. Inhibition of NF-kappa B DNA binding activity by alpha-tocopheryl succinate. Biochem Mol Biol Int 31: 693-700, 1993.
46. Tewes F, Böl G-F, and Brigelius-Flohé R. Thiol modulation inhibits the interleukin (IL)-1-mediated activation of an IL-1 receptor-associated protein kinase and NF-κB. Eur J Immunol 27: 3015-3021, 1997.
47. Tiku ML, Liesch JB, and Robertson FM. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines. J Immunol 145: 690-696, 1990.
48. Toledano MB, and Leonard WJ. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci U S A 88: 4328-4332, 1991.
49. Vig E, Green M, Liu Y, Donner DB, Mukaida N, Goebl MG, and Harrington MA. Modulation of tumor necrosis factor and interleukin-1-dependent NF-kappaB activity by mPLK/IRAK. J Biol Chem 274: 13077-13084, 1999.